하이퍼코퍼레이션
065650KOSDAQ기계장비 및 관련 물품 도매업35.5 / 100
Reference Date: 2026-04-13
Company InformationBased on 2025 Annual Report
Business Overview
Hyper Corporation operates three main business divisions: Commerce, Biopharma, and Tech. The Commerce division sells PC peripherals and household products, while the Biopharma division develops innovative drugs, including anti-inflammatory treatments, Alzheimer's therapies, and a non-opioid painkiller (MDR-652). The company is expanding its market through new ventures like the early dementia diagnostic kit QPLEX Alz Plus and the EcoVacs brand, driving revenue growth.
Number of Employees
83people
Average Salary
33.5M KRW
Score Calculation Basis
Detailed Financial Score
3.5x industry avg (risky)
Well below industry avg
6.4x industry avg (risky)
Avg ▲21.3% (2-year basis)
Avg ▼159.7% (2-year basis)
Avg ROE -103.0% (improving, 3yr)
Detailed News Sentiment
- Positive하이퍼코퍼레이션, 자본잠식 해소 및 흑자전환 성공
하이퍼코퍼레이션이 자본잠식 문제를 해결하고 흑자전환에 성공하여 관리종목에서 해제되었다.
- Negative거래소, 하이퍼코퍼레이션에 불성실공시법인 지정 예고
하이퍼코퍼레이션이 유상증자 공시 변경으로 인해 불성실공시법인 지정이 예고되었으며, 벌점 8점 이상 시 매매거래가 정지될 수 있다.
Detailed Momentum
Near 52w low (5%, downtrend)
1m -5.35% (slight drop)
Volume increasing
Detailed Disclosure
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-01
- Neutral대표이사변경2026-03-31
- Neutral정기주주총회결과2026-03-31
- Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
- Neutral감사보고서제출2026-03-23
